SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on November 4, 2021. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut, and its common stock trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a regulatory disclosure event rather than financial performance data.
Material Changes
Under Item 7.01 (Regulation FD Disclosure), the Company announced an expansion of its installation base in Texas. No other material financial changes or comparative period data were disclosed in this document.
Guidance, Outlook, and Risks
The Company explicitly stated it undertakes no obligation to update, supplement, or amend the materials regarding the Texas expansion. The filing includes standard disclaimers that the information is not deemed "filed" for Section 18 liability purposes under the Exchange Act and is not intended to constitute a determination of materiality under Regulation FD.
Investor Verification Checklist
- Verify the details of the Texas installation base expansion via the attached press release (Exhibit 99.1).
- Confirm the trading status of BSGM on the NASDAQ Capital Market.
- Note that this filing contains no audited financial statements or updated guidance.
- Review subsequent filings for any updates on the Texas expansion, as the Company disclaims an obligation to update this specific information.